Trial Profile
An Exploratory Randomized Placebo Controlled Trial of Milnacipran in Patients With Chronic Neuropathic Low Back Pain.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Jun 2017
Price :
$35
*
At a glance
- Drugs Milnacipran (Primary)
- Indications Back pain; Neuropathic pain
- Focus Therapeutic Use
- 27 Jul 2012 Actual end date (April 2012) added as reported by ClinicalTrials.gov.
- 04 Jan 2012 Planned End Date changed from 1 Dec 2011 to 1 Apr 2012 as reported by ClinicalTrials.gov.
- 04 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.